½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1313471

¼¼°èÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ±â¼ú, À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° - ¿¹Ãø(2023-2030³â)

Traumatic Brain Injury Assessment & Management Devices Market by Technique, Type, End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀåÀº 2023³â¿¡ 37¾ï 7,353¸¸ ´Þ·¯¿¡ À̸£°í, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 9.43%·Î Å©°Ô ¼ºÀåÇÏ¿© 2030³â¿¡´Â 71¾ï 57¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¼°èÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀ» Æò°¡Çϱâ À§Çؼ­ ÇʼöÀûÀÔ´Ï´Ù.»ç¾÷ Àü·«°ú Á¦Ç° ¸¸Á·µµ ÁÖ¿ä ÁöÇ¥¸¦ Á¶»çÇÏ¿© º¥´õ Á¾ÇÕ Æò°¡ Á¤º¸¸¦ Á¦°øÇÏ°í, »ç¿ëÀڴ ƯÁ¤ ¿ä±¸¿¡ ±Ù°ÅÇÑ Á¤º¸¸¦ ±âÃÊ·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ÀÌ Ã·´Ü ºÐ¼®¿¡ ÀÇÇØ º¥´õ´Â ¼º°ø Á¤µµ°¡ ´Ù¸¥ 4°³ »óÇÑÀ¸·Î Á¤¸®µË´Ï´Ù. ±×°ÍÀº Forefront(F), Pathfinder(P), Niche(N), Vital(V)ÀÔ´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼®

½ÃÀå Á¡À¯À² ºÐ¼®¿¡¼­´Â ƯÁ¤ ½ÃÀå ¿µ¿ª º¥´õ ÇöȲÀ» ÆľÇÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀüüÀûÀÎ ¸ÅÃâ, °í°´ ±â¹Ý, ±âŸ ÁÖ¿ä ÁöÇ¥¿¡ ´ëÇÑ º¥´õ ±â¿©µµ¸¦ ºñ±³ÇÏ´Â °ÍÀ¸·Î, ±â¾÷ÀÌ ½ÃÀå Á¡À¯À² °æÀïÀ» ÇÒ ¶§¿¡ ÀÚ»ç ½ÇÀûÀ̳ª Á÷¸éÇÏ°í ÀÖ´Â »óȲÀ» º¸´Ù ±í°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.¶ÇÇÑ º» ºÐ¼®¿¡¼­´Â Á¶»çÇÑ ±âÁس⵵¿¡ ƯÁ¤ ºÎ¹®ÀÌ ¾î´À Á¤µµ °æÀï ÇÏ°í ÀÖ´ÂÁö, ÃàÀû, ¼¼ºÐÈ­ ¿ìÀ§¼º, ÇÕº´ Ư¡¿¡ ´ëÇؼ­µµ ´Ù·ç¾ú½À´Ï´Ù.

º» º¸°í¼­´Â ´ÙÀ½ Æ÷ÀÎÆ®¿¡ °üÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÁÖ¿ä ±â¾÷ÀÌ Á¦°øÇÏ´Â ½ÃÀå¿¡ °üÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

2. ½ÃÀå ¹ßÀü : À¯¸®ÇÑ ½ÅÈï ½ÃÀå¿¡ °üÇÑ »ó¼¼ Á¤º¸¸¦ Á¦°øÇØ, ½ÃÀå ¼º¼÷ ºÎ¹® ħÅõµµ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ½ÅÁ¦Ç° Ãâ½Ã, ¹Ì°³¹ß Áö¿ª, ÃÖ±Ù °³¹ß, ÅõÀÚ¿¡ °üÇÑ »ó¼¼ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

4. ½ÃÀå µ¿Çâ : COVID-19, ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ºÐÀï, °íÀÎÇ÷¹À̼ÇÀÇ ´©Àû ¿µÇâÀ» Á¾ÇÕÀû¿¡ ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

5. °æÀï Æò°¡¿Í Á¤º¸ : ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À², Àü·«, Á¦Ç°, ÀÎÁõ, ±ÔÁ¦ »óȲ, ƯÇã »óȲ, Á¦Á¶´É·ÂÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÕ´Ï´Ù.

6. Á¦Ç° °³¹ß ¹× Çõ½Å : ÇâÈÄ ±â¼ú, ¿¬±¸°³¹ß È°µ¿, ȹ±âÀûÀÎ Á¦Ç° °³¹ß¿¡ °üÇÑ ÁöÀû ÅëÂûÀ» Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­¿¡¼­´Â ´ÙÀ½ Áú¹®¿¡ ´ëÇÑ ´äº¯À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

1. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå ±Ô¸ð ¹× ¿¹ÃøÀº?

2. ¿¹Ãø ±â°£Áß, ¼¼°èÀÇ ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀåÀ» Çü¼ºÇÏ´Â ¼ºÀå ¾ïÁ¦¿äÀΰú COVID-19ÀÇ ¿µÇâÀº?

3. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå¿¡¼­ ¿¹Ãø ±â°£Áß¿¡ ÅõÀÚÇØ¾ß ÇÒ Á¦Ç°/ºÎ¹®/¿ëµµ/ºÐ¾ß´Â?

4. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå °æÀï Àü·«Àº?

5. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå ±â¼ú µ¿Çâ°ú ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â?

6. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²Àº?

7. ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ¼¼°è ½ÃÀå Âü¿©¿¡´Â ¾î¶°ÇÑ Çüųª Àü·«ÀûÀÎ µ¿ÇâÀÌ ÀûÇÕÇÑ°¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå µ¿Çâ
  • COVID-19ÀÇ ´©Àû ¿µÇâ
  • ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ºÐÀïÀÇ ´©Àû ¿µÇâ
  • °íÀÎÇ÷¹À̼ÇÀÇ ´©Àû ¿µÇâ
  • PorterÀÇ Five Forces ºÐ¼®
  • ¹ë·ùüÀΰú Áß¿ä °æ·Î ºÐ¼®
  • ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©
  • °í°´ Ä¿½ºÅ͸¶ÀÌÁî

Á¦6Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ±â¼úº°

  • ¼­·Ð
  • µÎ°³³» ¾Ð(ICP) ¸ð´ÏÅ͸µ
  • ³úÁ¶Á÷³» »ê¼Ò ºÐ¾Ð(pBrO2)

Á¦7Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : À¯Çüº°

  • ¼­·Ð
  • À̹Ì¡ Àåºñ
  • °¨½Ã Àåºñ

Á¦8Àå ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¼­·Ð
  • Áø´Ü¼¾ÅÍ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä« ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • ¼­·Ð
  • ¾Æ¸£ÇîƼ³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • ¼­·Ð
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¿Ü»ó¼º ³ú¼Õ»ó Æò°¡ ¹× °ü¸® ±â±â ½ÃÀå

  • ¼­·Ð
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍÅ°
  • ¾Æ¶ø¿¡¹Ì¸®Æ®
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ÁÖ¿ä ±â¾÷º°
  • °æÀï ½Ã³ª¸®¿À ºÐ¼® : ÁÖ¿ä ±â¾÷º°

Á¦13Àå °ÔÀç ±â¾÷ ¸®½ºÆ®

Á¦14Àå ºÎ·Ï

  • µð½ºÄ¿¼Ç °¡À̵å
  • ¶óÀ̼±½º¿Í °¡°Ý¿¡ ´ëÇØ
LSH 23.09.27

The Global Traumatic Brain Injury Assessment & Management Devices Market is forecasted to grow significantly, with a projected USD 3,773.53 million in 2023 at a CAGR of 9.43% and expected to reach a staggering USD 7,100.57 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Traumatic Brain Injury Assessment & Management Devices Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Traumatic Brain Injury Assessment & Management Devices Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Technique, market is studied across Intracranial Pressure (ICP) Monitoring and Partial Pressure of Oxygen In Brain Tissue (pBrO2). The Partial Pressure of Oxygen In Brain Tissue (pBrO2) is projected to witness significant market share during forecast period.

Based on Type, market is studied across Imaging Devices and Monitoring Devices. The Monitoring Devices is projected to witness significant market share during forecast period.

Based on End User, market is studied across Diagnostic Centers and Hospitals. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Traumatic Brain Injury Assessment & Management Devices Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Traumatic Brain Injury Assessment & Management Devices Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Traumatic Brain Injury Assessment & Management Devices Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Traumatic Brain Injury Assessment & Management Devices Market?

4. What is the competitive strategic window for opportunities in the Global Traumatic Brain Injury Assessment & Management Devices Market?

5. What are the technology trends and regulatory frameworks in the Global Traumatic Brain Injury Assessment & Management Devices Market?

6. What is the market share of the leading vendors in the Global Traumatic Brain Injury Assessment & Management Devices Market?

7. What modes and strategic moves are considered suitable for entering the Global Traumatic Brain Injury Assessment & Management Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Traumatic Brain Injury Assessment & Management Devices Market, by Technique, 2022 vs 2030
  • 4.3. Traumatic Brain Injury Assessment & Management Devices Market, by Type, 2022 vs 2030
  • 4.4. Traumatic Brain Injury Assessment & Management Devices Market, by End User, 2022 vs 2030
  • 4.5. Traumatic Brain Injury Assessment & Management Devices Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of traumatic brain injuries
      • 5.1.1.2. Inclination towards minimally invasive procedures
      • 5.1.1.3. Several approvals for the devices in recent years
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of advanced assessment & management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. R&D investment for product advancement
      • 5.1.3.2. Awareness programs and initiatives by healthcare organizations across the globe
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Traumatic Brain Injury Assessment & Management Devices Market, by Technique

  • 6.1. Introduction
  • 6.2. Intracranial Pressure (ICP) Monitoring
  • 6.3. Partial Pressure of Oxygen In Brain Tissue (pBrO2)

7. Traumatic Brain Injury Assessment & Management Devices Market, by Type

  • 7.1. Introduction
  • 7.2. Imaging Devices
  • 7.3. Monitoring Devices

8. Traumatic Brain Injury Assessment & Management Devices Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Hospitals

9. Americas Traumatic Brain Injury Assessment & Management Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Traumatic Brain Injury Assessment & Management Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Traumatic Brain Injury Assessment & Management Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦